Permissive Hypercapnia in Extremely Low Birthweight Infants

ISRCTN ISRCTN56143743
DOI https://doi.org/10.1186/ISRCTN56143743
Secondary identifying numbers N/A
Submission date
29/12/2006
Registration date
05/01/2007
Last edited
18/04/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Ulrich Herbert Thome
Scientific

Eythstr 24
Ulm
89075
Germany

Study information

Study designRandomised controlled multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titlePermissive Hypercapnia in Extremely Low Birthweight Infants
Study acronymPHELBI
Study hypothesisA higher than traditional arterial carbon dioxide pressure (PaCO2) target range (permissive hypercapnia) in mechanically ventilated extremely low birth weight infants reduces the combined incidence of bronchopulmonary dysplasia or death.
Ethics approval(s)Ethics committee of the University of Ulm, 15/12/2006, ref: 230/06
ConditionInfant respiratory distress syndrome
InterventionDifferent PaCO2 target range:
Experimental intervention: PaCO2 target range 55 to 65 mmHg (day one to three of life) , 60 to 70 mmHg (day four to six), 65 to 75 mmHg (day seven to 14).
Control intervention: PaCO2 target range 40 to 50 mmHg on day one to three, 45 to 55 mmHg on days four to six, 50 to 60 mmHg on day seven to 14.
Intervention typeProcedure/Surgery
Primary outcome measure1. Bronchopulmonary dysplasia at 36 weeks postmenstrual age
2. Death by intention to treat
Secondary outcome measures1. Incidence of intracranial haemorrhages
2. Incidence of air leaks
3. Duration of mechanical ventilation
4. Positive pressure support and supplemental oxygen
5. Inflammatory mediators in tracheal aspirates
6. Neurodevelopmental outcome at 18 to 24 months corrected age, per protocol ananlysis of primary outcome
Overall study start date31/12/2007
Overall study end date31/12/2011

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants830
Participant inclusion criteriaExtremely low birthweight infants (400 g to 1000 g) requiring mechanical ventilation within 24 hours after birth
Participant exclusion criteriaCongenital malformations affecting respiratory or cardiac function or requiring surgery
Recruitment start date31/12/2007
Recruitment end date31/12/2011

Locations

Countries of recruitment

  • Germany

Study participating centre

Eythstr 24
Ulm
89075
Germany

Sponsor information

University Hospital Ulm (Universitätsklinikum Ulm) (Germany)
Hospital/treatment centre

Albert-Einstein-Allee 29
Ulm
89070
Germany

Phone +49 (0)731 500 0
Email klinikumsvorstand@uniklinik-ulm.de
Website http://www.uniklinik-ulm.de/
ROR logo "ROR" https://ror.org/05emabm63

Funders

Funder type

Government

Deutsche Forschungsgemeinschaft (Germany) (ref: Th 626/5-1)
Government organisation / National government
Alternative name(s)
German Research Association, German Research Foundation, DFG
Location
Germany

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2015 Yes No
Results article results 13/03/2018 Yes No

Editorial Notes

18/04/2018: Publication reference added.